Skip to content

Released Nov 12, 2019, after the close

10-Q filed Nov 12, 2019, 43 days after period end · 0001104659-19-062585

Q3 2019 · 10-Q
Revenue$164.99K— vs Q3 2018no prior Q2 2019 on file
Net Income-$3.06MN/M vs Q3 2018N/M vs Q2 2019
EPS Diluted-$0.12N/M vs Q3 2018N/M vs Q2 2019
Operating Income-$2,975,688N/M
Operating Cash Flowderived-$2,797,368N/M
Margins · derived
Operating margin-1803.6%
Net margin-1854.8%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2019Q3 2018Q3 2017Q3 2016
Revenue$164.99K$0.00$0.00—
Net Income-$3.06M-$2.46M-$4.70M-$3.24M
EPS Diluted-$0.12-$0.12-$0.22-$0.18

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR